Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

After careers in venture capital and leading operations at Naturals Salons, Sanjay Enishetty turned his attention to what he ...

Changing your rep range and your workout intensity can help you build more muscle, says an exercise scientist with decades of ...